Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Current Sleep Medicine Reports
Erschienen in:

16.05.2023

The Insomnia-Suicide Link Across the Life Cycle: a Review

verfasst von: Hunter Spivey, Amal Asiri, Matthew M. Kridel, Thashi Uppalapati, Dale Peeples, William V. McCall

Erschienen in: Current Sleep Medicine Reports | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Purposeof Review

The purpose of this review is to examine the literature regarding the link between suicidal ideation and behavior with insomnia and briefly discuss how treatment of the latter may reduce the former.

Recent Findings

We considered the literature in three categories: adolescents, non-elderly adults and elderly adults. Each group had distinct presentations; adolescents displayed increased hopelessness as insomnia symptom severity increased, non-elderly adults displayed elevated rates of impulsive behavior and lastly older persons displayed increasing and persistent levels of depression related to thwarted belongingness as they transitioned into late life. Possible mechanisms underlying the suicide-insomnia link varied with each group; however, increasing insomnia symptom severity increased risk for suicide for all groups.
Literatur
1.
2.
Lönnqvist J. Mood and anxiety disorders in suicide and suicide attempters. In: Wasserman D, Wasserman C, Wasserman D, editors. Oxford textbook of suicidology and suicide prevention Oxford University Press; 2021. pp. 261–8.
3.
American psychiatric association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
4.
Freeman D, Sheaves B, Waite F, Harvey AG, Harrison PJ. Sleep disturbance and psychiatric disorders. The Lancet Psychiatry. 2020;7:628–37.CrossRefPubMed
5.
Gregory AM, Sadeh A. Annual research review: sleep problems in childhood psychiatric disorders - a review of the latest science. J Child Psychol Psychiatry. 2015;57:296–317.CrossRefPubMed
6.
Adjaye-Gbewonyo D, Ng AE, Black LI. Sleep difficulties in adults: United States, 2020. NCHS Data Brief 2022(436):1–8.
7.
Sateia MJ. International classification of sleep disorders-third edition. Chest. 2014;146:1387–94.CrossRefPubMed
8.
Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17:241–54.CrossRefPubMedPubMedCentral
9.
Sashi I, Kapur N, Appleby L. A prospective study of noncompliance with medication, suicidal ideation, and suicidal behavior in recently discharged psychiatric inpatients. Arch Suicide Res. 2006;10:61–7.CrossRef
10.•
Saulnier KG, Singh R, Lenker KP, Calhoun SL, He F, Liao D, Vgontzas AN, Bixler EO, Fernandez-Mendoza J. Association of insomnia phenotypes based on polysomnography-measured sleep duration with suicidal ideation and attempts. Sleep Health. 2022;8:391–7. PSG measured sleep duration and clinical outcomes of insomnia subtypesCrossRefPubMedPubMedCentral
11.
Rumble ME, McCall WV, Dickson DA, Krystal AD, Rosenquist PB, Benca RM. An exploratory analysis of the Association of Circadian rhythm dysregulation and insomnia with suicidal ideation over the course of treatment in individuals with depression, insomnia, and suicidal ideation. J Clin Sleep Med. 2020;16:1311–9.CrossRefPubMedPubMedCentral
12.
Yellman MA, Bryan L, Sauber-Schatz EK, Brener N. Transportation risk behaviors among high school students — youth risk behavior survey, United States, 2019. MMWR Supplements. 2020;69:77–83.CrossRefPubMedPubMedCentral
13.
14.
Russell K, Rasmussen S, Hunter SC. Insomnia and nightmares as markers of risk for suicidal ideation in young people: investigating the role of defeat and entrapment. J Clin Sleep Med. 2018;14:775–84.CrossRefPubMedPubMedCentral
15.
Mack A. Sleep disturbance preceding completed suicide in adolescents. Yearbook of Psychiat and Appl Mental Health. 2009;2009:7.CrossRef
16.•
Wolfe KL, Nakonezny PA, Owen VJ, et al. Hopelessness as a predictor of suicide ideation in depressed male and female adolescent youth. Suicide Life Threat Behav. 2019;49(1):253–63. Proposed hopelessness as mediator of suicide-insomnia link.
17.
Su S, Li X, Xu Y, McCall WV, Wang X. Epidemiology of accelerometer-based sleep parameters in US school-aged children and adults: NHANES 2011–2014. Sci Rep. 2022;12(1):7680.
18.
Chu C, Hom MA, Rogers ML, Ringer FB, Hames JL, Suh S, Joiner TE. Is insomnia lonely? Exploring thwarted belongingness as an explanatory link between insomnia and suicidal ideation in a sample of South Korean University students. J Clin Sleep Med. 2016;12:647–52.CrossRefPubMedPubMedCentral
19.
Bernert RA, Turvey CL, Conwell Y, Joiner TE. Association of poor subjective sleep quality with risk for death by suicide during a 10-year period: a longitudinal, population-based study of late life. JAMA Psychiatry. 2014;71:1129–1137.
20.
Zhao D, Li J, Hao W, et al. The relationship between activities of daily living and suicidal ideation among Chinese rural older adults: a multiple mediation model through sleep quality and psychological distress. Aging. 2020;12(22):22614–22625.
21.
Gunnell D, Chang S-S, Tsai MK, Tsao CK, Wen CP. Sleep and suicide: an analysis of a cohort of 394,000 Taiwanese adults. Soc Psychiatry Psychiatr Epidemiol. 2013;48:1457–65.CrossRefPubMed
22.
Simmons Z, Burlingame G, Korbanka J, et al. Insomnia symptom severity is associated with increased suicidality and death by suicide in a sample of patients with psychiatric disorders. Sleep. 2021;44(7).
23.
Turvey CL, Conwell Y, Jones MP, Phillips C, Simonsick E, Pearson JL, Wallace R. Risk factors for late-life suicide: a prospective, community-based study. Am J Geriatr Psychiatry. 2002;10:398–406.CrossRefPubMed
24.
McCall WV, Benca RM, Rosenquist PB, Riley MA, McCloud L, Newman JC, Case D, Rumble M, Krystal AD. Hypnotic medications and suicide: risk, mechanisms, mitigation, and the FDA. Am J Psychiatry. 2017;174:18–25.CrossRefPubMed
25.
Ploderl M. Suicide risk over the course of the day, week, and life. Psychiatr Danub. 2021;33:438–45.CrossRefPubMed
26.
McCall WV. Management of primary sleep disorders among elderly persons [published erratum appears in Psychiatr Serv 1995 feb;46(2):156]. Psychiatr Serv. 1995;46:49–55.CrossRefPubMed
27.
McCall WV. Sleep in the elderly. The primary care companion to The J Clin Psychiat. 2004;06:9–20.CrossRef
28.
Reynolds CF III, Regestein Q, Nowell PD, et al. Treatment of insomnia in the elderly. In: Salzman C, editor., et al., Clinical Geriatric Psychopharmacology. 3rd ed. Baltimore, MD: Williams & Wilkins; 1998. p. 395–416.
29.
Kay DB, Dombrovski AY, Buysse DJ, Reynolds CF, Begley A, Szanto K. Insomnia is associated with suicide attempt in middle-aged and older adults with depression. Int Psychogeriatr. 2015;28:613–9.CrossRefPubMedPubMedCentral
30.•
McCall WV, Benca RM, Rosenquist PB, et al. Reducing suicidal ideation through insomnia treatment (rest-it): a randomized clinical trial. Am J Psychiatry. 2019;176:957–65. This paper showed that targeted pharmacological treatment of insomnia reduces suicidal ideation.CrossRefPubMedPubMedCentral
31.
Lavigne JE, Hur K, Kane C, Au A, Bishop TM, Pigeon WR. Prescription medications for the treatment of insomnia and risk of suicide attempt: a comparative safety study. J Gen Intern Med. 2019;34:1554–63.CrossRefPubMedPubMedCentral
32.
Shapiro CM, Blake F, Fossey E, Adams B. Daylight saving time in psychiatric illness. J Affect Disord. 1990;19:177–81.CrossRefPubMed
33.
Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D. Cognitive behavioral therapy for chronic insomnia. Ann Intern Med. 2015;163:191–204.CrossRefPubMed
34.
Ma ZR, Shi LJ, Deng MH. Efficacy of cognitive behavioral therapy in children and adolescents with insomnia: a systematic review and meta-analysis. Braz J Med Biol Res. 2018;51(6):e7070.
35.
Huang K, Li S, He R, Zhong T, Yang H, Chen L, Gao H, Jia Y. Efficacy of cognitive behavioral therapy for insomnia (CBT-I) in older adults with insomnia: a systematic review and meta-analysis. Australas Psychiatry. 2022;30:592–7.CrossRefPubMed
36.
Koffel EA, Koffel JB, Gehrman PR. A meta-analysis of group cognitive behavioral therapy for insomnia. Sleep Med Rev. 2015;19:6–16.CrossRefPubMed
37.
Soh HL, Ho RC, Ho CS, Tam WW. Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trials. Sleep Med. 2020;75:315–25.CrossRefPubMed
38.
Brown GK, Ten Have T, Henriques GR, Xie SX, Hollander JE, Beck AT. Cognitive therapy for the prevention of suicide attempts. JAMA. 2005;294:563.CrossRefPubMed
39.
Linehan MM, Korslund KE, Harned MS, et al. Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis. JAMA Psychiatry. 2015;72(5):475–82.
40.
Zalsman G, Hawton K, Wasserman D, et al. Suicide prevention strategies revisited: 10-year systematic review. The Lancet Psychiatry. 2016;3:646–59.CrossRefPubMed
41.
Pigeon WR, Funderburk JS, Cross W, Bishop TM, Crean HF. Brief CBT for insomnia delivered in primary care to patients endorsing suicidal ideation: a proof-of-concept randomized clinical trial. Translational Behavioral Medicine. 2019;9:1169–77.CrossRefPubMed
42.
Kalmbach DA, Cheng P, Ahmedani BK, et al. Cognitive-behavioral therapy for insomnia prevents and alleviates suicidal ideation: insomnia remission is a suicidolytic mechanism. Sleep. 2022;45(12).
43.
44.•
Bossini L, Coluccia A, Casolaro I, Benbow J, Amodeo G, De Giorgi R, Fagiolini A. Off-label trazodone prescription: evidence, benefits and risks. Curr Pharm Des. 2015;21:3343–51. Highlighted dangers of off label prescription usage.CrossRefPubMed
Metadaten
Titel
The Insomnia-Suicide Link Across the Life Cycle: a Review
verfasst von
Hunter Spivey
Amal Asiri
Matthew M. Kridel
Thashi Uppalapati
Dale Peeples
William V. McCall
Publikationsdatum
16.05.2023
Verlag
Springer International Publishing
Erschienen in
Current Sleep Medicine Reports / Ausgabe 3/2023
Elektronische ISSN: 2198-6401
DOI
https://doi.org/10.1007/s40675-023-00256-7

Weitere Artikel der Ausgabe 3/2023

Co-morbid Insomnia and Sleep Apnoea (COMISA): Latest Research from an Emerging Field

  • Open Access

Valerian for Insomnia on Subjective and Objective Sleep Parameters: a Meta-analysis of Randomized Controlled Trials

Error Propagation from Sleep Stage Classification to Derived Sleep Parameters in Machine Learning on Data from Wearables

  • Open Access

The Worldwide Prevalence of Sleep Problems Among Medical Students by Problem, Country, and COVID-19 Status: a Systematic Review, Meta-analysis, and Meta-regression of 109 Studies Involving 59427 Participants

Later School Start Times as a Public Health Intervention to Promote Sleep Health in Adolescents

  • Open Access

Too Sour to be True? Tart Cherries (Prunus cerasus) and Sleep: a Systematic Review and Meta-analysis

  • Open Access

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Neuartige Antikörpertherapie bremst MS über zwei Jahre hinweg

Eine Therapie mit dem C40-Ligand-Blocker Frexalimab kann MS-Schübe und neue MRT-Läsionen über zwei Jahre hinweg verhindern. Dafür spricht die Auswertung einer offen fortgeführten Phase-2-Studie.

Positive Phase IIb-Studie zu mRNA-gestützter CAR-T bei Myasthenia gravis

Eine auf das B-Zell-Reifungsantigen gerichtete mRNA-basierte CAR-T-Zell-Therapie wurde jetzt in einer ersten Phase IIb-Studie zur Behandlung der generalisierten Myasthenia gravis mit Placebo verglichen.

Therapiestopp bei älteren MS-Kranken kann sich lohnen

Eine Analyse aus Kanada bestätigt: Setzen ältere MS-Kranke die Behandlung mit Basistherapeutika ab, müssen sie kaum mit neuen Schüben und MRT-Auffälligkeiten rechnen.

Schadet Schichtarbeit dem Gehirn?

Eine große Registerstudie bestätigt, dass Schichtarbeit mit einem erhöhten Risiko für psychische und neurologische Erkrankungen einhergeht, sowie mit einer Volumenabnahme in Gehirnarealen, die für Depression, Angst und kognitive Funktionen relevant sind.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise